Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?

被引:35
作者
Hishida, T
Nagai, K
Yoshida, J
Nishimura, M
Ishii, G
Iwasaki, M
Nishiwaki, Y
机构
[1] Natl Canc Ctr Hosp E, Dept Thorac Oncol, Chiba 2778577, Japan
[2] Natl Canc Ctr Res Inst E, Div Pathol, Chiba, Japan
[3] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan
关键词
D O I
10.1016/j.jtcvs.2005.11.028
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives: Some investigators have reported long-term survival after surgical resection of a solitary non - small cell lung cancer recurrence in various sites. However, the role and indications of the second operation remain unclear. Methods: We reviewed 28 patients with a solitary recurrence after successful initial resection of primary non - small cell lung cancer who underwent resection of the recurrent lesion. The clinicopathologic factors associated with outcome were analyzed. Results: There were 17 men and 11 women. Recurrence resection was performed for the following sites: 16 in the lung, 5 in the brain, 2 in the adrenal gland, and 1 each in the chest wall, stomach, skin, pelvic lymph node, and malar bone. The median survival time was 25 months, and the 1-, 2-, and 5-year survival rates after recurrence were 89%, 59%, and 32%, respectively. Advanced p-stage ( p-stage II and III, n = 14) of the primary tumor was the significant negative prognostic factor. Patients with p-stage II or III had survival equivalent to that of those who had multiple recurrences or were unfit for further surgical intervention. Conclusions: Resection of a solitary non - small cell lung cancer recurrence might provide long-term survival in highly selected patients. However, surgical resection might be contraindicated if the primary tumor is stage II or III.
引用
收藏
页码:838 / 842
页数:5
相关论文
共 26 条
[1]
Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients [J].
Abrahams, JM ;
Torchia, M ;
Putt, M ;
Kaiser, LR ;
Judy, KD .
JOURNAL OF NEUROSURGERY, 2001, 95 (04) :595-600
[2]
ALBERTI W, 1995, BRIT MED J, V311, P899
[3]
Benefits of resection for metachronous lung cancer [J].
Battafarano, RJ ;
Force, SD ;
Meyers, BF ;
Bell, J ;
Guthrie, TJ ;
Cooper, JD ;
Patterson, GA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (03) :836-842
[4]
Surgical treatment of malignant melanoma [J].
Essner, R .
SURGICAL CLINICS OF NORTH AMERICA, 2003, 83 (01) :109-+
[5]
Fong YM, 1999, SEMIN ONCOL, V26, P514
[6]
Non-small cell lung cancer with single brain metastasis: the role of surgical treatment [J].
Granone, P ;
Margaritora, S ;
D'Andrilli, A ;
Cesario, A ;
Kawamukai, K ;
Meacci, E .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 20 (02) :361-366
[7]
HELLWIG D, 2005, EUR J NUCL MED 0909
[8]
*INT UN CANC, 1997, TNM CLASS MAL TUM
[9]
Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer:: A prospective study [J].
Kalff, V ;
Hicks, RJ ;
MacManus, MP ;
Binns, DS ;
McKenzie, AF ;
Ware, RE ;
Hogg, A ;
Ball, DL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :111-118
[10]
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer [J].
Lardinois, D ;
Weder, W ;
Roudas, M ;
von Schulthess, GK ;
Tutic, M ;
Moch, H ;
Stahel, RA ;
Steinert, HC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6846-6853